Mylotarg has potent anti-leukaemic effect: a systematic review and meta-analysis of anti-CD33 antibody treatment in acute myeloid leukaemia
Justin Loke(Dana-Farber Cancer Institute), Keith Wheatley(Cancer Research UK Clinical Trials Unit)
Cited by 69
Related Papers
Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial
|Journal of Clinical Oncology|2013|415
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children
|New England Journal of Medicine|2020|308
Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12
|Journal of Clinical Oncology|2010|305
Attempts to Optimize Induction and Consolidation Treatment in Acute Myeloid Leukemia: Results of the MRC AML12 Trial
|Journal of Clinical Oncology|2009|229
Results of a randomized trial in children with Acute Myeloid Leukaemia: Medical Research Council AML12 trial
|British Journal of Haematology|2011|205